Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04986683 · ClinicalTrials.gov registry record · NA

Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery

A NA study of Focal Epilepsy, sponsored by Wayne State University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04986683: Recruiting NA study of Focal Epilepsy, sponsored by Wayne State University.

NCT04986683 is a NA study of Focal Epilepsy that is actively recruiting participants, run by Wayne State University. The registered enrollment target is 60 participants, below the 165-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04986683, a NA study of Focal Epilepsy, is actively recruiting participants, sponsored by Wayne State University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability (i.e., functional deficit) and maximize surgical benefit probability (i.e., seizure freedom) by precisely localizing eloquent white matter pathways in children and adolescents with drug-resistant focal epilepsy. This new imaging approach, which will acquire a DWMRI scan before pediatric epilepsy surgery in about 10 minutes without contrast administration (and also without sedation even in young children), can be readily applied to improve preoperative benefit-risk evaluation for pediatric epilepsy surgery in the future. The investigators will also study how the advanced DWMRI-DCNN connectome approach can detect complex signs of brain neuronal reorganization that help improve neurological and cognitive outcomes following pediatric epilepsy surgery. This new imaging approach could benefit targeted interventions in the future to minimize neurocognitive deficits in affected children. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals. The findings of this project will not guide any clinical decision-making or clinical intervention until the studied approach is thoroughly validated.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Brain magnetic resonance imaging
  • BEHAVIORAL Neuro-psychology testing

Study Locations (1)

Michigan

  • Wayne State University/Children's Hospital of Michigan - Detroit

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-08-01
Est. Completion 2026-06-30
Phase NA
Wayne State University

163 total trials

What NCT04986683 shows while recruiting

NCT04986683 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 165-participant average among 8 other Focal Epilepsy trials with a reported enrollment target (64% lower).

The record links to 1 condition, with Focal Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Brain magnetic resonance imaging is the first listed.

NCT04986683 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04986683 about?

NCT04986683 is a clinical study titled "Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery". This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability ...

What is the current status of trial NCT04986683?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2021-08-01. Estimated completion is 2026-06-30.

What conditions does trial NCT04986683 study?

This clinical trial studies the following conditions: Focal Epilepsy.

What interventions are being tested in trial NCT04986683?

The interventions under investigation include: Brain magnetic resonance imaging (DIAGNOSTIC_TEST), Neuro-psychology testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04986683?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04986683 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Focal Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04986683's enrollment target sits among peer trials

60 5th of 8 higher than 4 of 8 other Focal Epilepsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Focal Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04986683, the US trial registry maintained by the National Library of Medicine. NCT04986683 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.